← All stocks

RELMADA THERAPEUTICS, INC.

RLMD Net buying
CIK 0001553643 #3112 in the set updated 17 Sep 2026
Bought (12 mo)
$4.03M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$4.03M
+$4.03M against sales at will

By person

5 insiders · 10 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Shenouda Maged
Chief Financial Officer
$1.99M (4)
+$1.99M
1,000,000
$4.10M
+1,032%
TRAVERSA SERGIO
Chief Executive Officer
$1.54M (4)
+$1.54M
1,500,000
$6.15M
+290.6%
Ence Chuck
CA and CO
$299.20K (1)
+$299.20K
403,931
$1.66M
+936.5%
Kelly Paul Edward
COO
$198.00K (1)
+$198.00K
502,295
$2.06M
+136.6%
CASAMENTO CHARLES J
Director
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 3.5 over the window, from 30,174,202 to 106,669,846 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 13
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 6 Oct 2017